Chr. Hansen Holding A/S

Basic Materials US CRTSF

NoneUSD
0.00(0%)

Last update at 2024-03-07T21:02:43.039235Z

Day Range

LowHigh

52 Week Range

61.4379.54

LowHigh

Fundamentals

Previous Close 79.30
Market Cap10785.99M
VolumeNone
P/E Ratio41.52
Dividend Yield1.38%
EBITDA472.70M
Revenue TTM1334.40M
Revenue Per Share TTM10.11
Gross Profit TTM 723.30M
Diluted EPS TTM1.91

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2023-08-31	2022-08-31	2021-08-31	2020-08-31	2019-08-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-08-31	2022-08-31	2021-08-31	2020-08-31	2019-08-31
Income before tax	-	292.90M	247.10M	295.60M	324.80M
Minority interest	-	-	-	-	0.00000M
Net income	-	225.10M	845.20M	245.00M	250.20M
Selling general administrative	-	82.00M	73.10M	53.30M	71.10M
Selling and marketing expenses	-	173.90M	154.80M	135.10M	158.50M
Gross profit	-	676.50M	613.40M	584.00M	650.00M
Reconciled depreciation	-	107.10M	101.20M	83.90M	64.60M
Ebit	358.80M	314.90M	287.50M	321.60M	345.30M
Ebitda	-	422.00M	388.70M	405.50M	409.90M
Depreciation and amortization	-	107.10M	101.20M	83.90M	64.60M
Non operating income net other	-	-	-	-	0.00000M
Operating income	-	320.90M	276.20M	313.00M	340.90M
Other operating expenses	-3.70000M	892.20M	779.30M	643.10M	817.90M
Interest expense	-	10.50M	20.40M	13.10M	14.30M
Tax provision	-	67.80M	48.40M	64.00M	74.60M
Interest income	-	2.20M	1.90M	3.70M	5.10M
Net interest income	-	-13.60000M	-21.40000M	-13.80000M	-12.40000M
Extraordinary items	-	-	-	-	0.00000M
Non recurring	-	-	-	-	0.00000M
Other items	-	-	-	-	0.00000M
Income tax expense	70.30M	67.80M	48.40M	64.00M	74.60M
Total revenue	-	1218.00M	1077.40M	970.00M	1161.10M
Total operating expenses	-	350.70M	315.30M	257.10M	306.80M
Cost of revenue	-	541.50M	464.00M	386.00M	511.10M
Total other income expense net	-	-28.00000M	-29.10000M	-17.40000M	-16.10000M
Discontinued operations	-	-	646.50M	13.40M	21.00M
Net income from continuing ops	-	225.10M	198.70M	231.60M	250.20M
Net income applicable to common shares	227.00M	225.10M	845.20M	245.00M	250.20M
Preferred stock and other adjustments	-	-	-	-	0.00000M

Breakdown	2023-08-31	2022-08-31	2021-08-31	2020-08-31	2019-08-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-08-31	2022-08-31	2021-08-31	2020-08-31	2019-08-31
Total assets	-	3316.80M	3114.20M	2853.60M	2057.80M
Intangible assets	-	357.60M	379.50M	321.70M	225.50M
Earning assets	-	-	-	-	-
Other current assets	-	-	-	202.40M	0.00000M
Total liab	-	3135.90M	1488.10M	1960.60M	1260.60M
Total stockholder equity	-	180.90M	1626.10M	893.00M	797.20M
Deferred long term liab	-	-	-	-	0.00000M
Other current liab	186.50M	144.70M	156.90M	230.90M	130.50M
Common stock	176.90M	177.30M	177.30M	177.10M	176.80M
Capital stock	-	177.30M	177.30M	177.10M	176.80M
Retained earnings	1756.80M	1643.00M	1527.40M	799.90M	671.90M
Other liab	244.60M	252.30M	233.80M	206.60M	176.30M
Good will	-	1517.60M	1489.80M	1249.10M	772.90M
Other assets	90.80M	64.10M	23.80M	12.10M	7.60M
Cash	-	82.80M	55.10M	96.20M	87.40M
Cash and equivalents	-	-	-	-	-
Total current liabilities	362.30M	387.20M	451.80M	1017.30M	360.90M
Current deferred revenue	-	142.90M	155.10M	229.10M	128.70M
Net debt	-	880.60M	898.20M	1325.70M	734.40M
Short term debt	-	110.00M	162.80M	685.20M	98.30M
Short long term debt	-	97.00M	150.70M	-	96.20M
Short long term debt total	-	963.40M	953.30M	1421.90M	821.80M
Other stockholder equity	-33.50000M	-1639.40000M	-78.60000M	715.90M	620.40M
Property plant equipment	981.80M	877.40M	782.10M	654.80M	577.80M
Total current assets	521.20M	498.40M	429.30M	607.10M	474.00M
Long term investments	-	-	-	-	0.00000M
Net tangible assets	67.10M	-51.30000M	-243.20000M	-677.80000M	-201.20000M
Short term investments	-	-	-	-	0.00000M
Net receivables	256.20M	222.10M	227.20M	173.80M	215.60M
Long term debt	-	767.70M	705.20M	-	668.90M
Inventory	194.20M	180.60M	133.90M	122.30M	160.00M
Accounts payable	111.50M	132.50M	132.10M	101.20M	132.10M
Total permanent equity	-	-	-	-	0.00000M
Noncontrolling interest in consolidated entity	-	-	-	-	0.00000M
Temporary equity redeemable noncontrolling interests	-	-	-	-	0.00000M
Accumulated other comprehensive income	-	-	-	-	0.00000M
Additional paid in capital	-	-	-	-	0.00000M
Common stock total equity	-	-	-	-	0.00000M
Preferred stock total equity	-	-	-	-	0.00000M
Retained earnings total equity	-	-	-	-	0.00000M
Treasury stock	-	-	-	-	0.00000M
Accumulated amortization	-	-	-	-	0.00000M
Non currrent assets other	-	53.10M	22.60M	13.90M	1583.80M
Deferred long term asset charges	-	-	-	-	0.00000M
Non current assets total	-	2818.40M	2684.90M	2246.50M	1583.80M
Capital lease obligations	-	98.70M	97.40M	-	56.70M
Long term debt total	-	-	-	-	0.00000M

Breakdown	2023-08-31	2022-08-31	2021-08-31	2020-08-31	2019-08-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-08-31	2022-08-31	2021-08-31	2020-08-31	2019-08-31
Investments	-12.50000M	-152.40000M	-7.40000M	-5.50000M	-5.50000M
Change to liabilities	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Total cashflows from investing activities	-176.30000M	-152.40000M	284.50M	-807.50000M	-81.60000M
Net borrowings	-35.90000M	-17.10000M	-532.40000M	595.40M	38.00M
Total cash from financing activities	-158.70000M	-142.20000M	-637.20000M	456.80M	-200.50000M
Change to operating activities	-60.50000M	-32.50000M	-5.00000M	16.20M	-24.20000M
Net income	227.00M	320.90M	276.20M	313.00M	340.90M
Change in cash	-26.80000M	27.70M	-41.10000M	8.80M	18.30M
Begin period cash flow	82.80M	55.10M	96.20M	87.40M	69.10M
End period cash flow	-	82.80M	55.10M	96.20M	87.40M
Total cash from operating activities	316.90M	308.80M	310.80M	364.60M	298.60M
Issuance of capital stock	-	-	-	-	0.00000M
Depreciation	113.90M	107.10M	101.20M	83.90M	64.60M
Other cashflows from investing activities	-27.30000M	-10.80000M	766.00M	-26.00000M	46.30M
Dividends paid	-124.70000M	-115.90000M	-115.80000M	-124.70000M	-224.30000M
Change to inventory	-	-	-	-	0.00000M
Change to account receivables	-	-	-	-	0.00000M
Sale purchase of stock	-	-9.20000M	-10.40000M	0.00000M	-5.30000M
Other cashflows from financing activities	-	150.00M	701.60M	975.50M	306.90M
Change to netincome	36.50M	9.70M	-630.50000M	33.20M	15.30M
Capital expenditures	116.20M	141.60M	155.90M	118.80M	139.60M
Change receivables	-	-	-	-	0.00000M
Cash flows other operating	-	-	-	-	0.00000M
Exchange rate changes	-	-	-	-	0.00000M
Cash and cash equivalents changes	-	-	-	-	0.00000M
Change in working capital	-	-32.50000M	-5.10000M	17.20M	-24.10000M
Stock based compensation	-	7.90M	3.90M	-0.50000M	0.40M
Other non cash items	-	-94.60000M	-65.40000M	-49.00000M	-83.20000M
Free cash flow	-	167.20M	154.90M	245.80M	159.00M

Peer Comparison

Sector: Basic Materials Industry: Specialty Chemicals

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
CRTSF Chr. Hansen Holding A/S	- -%	-	41.52	34.48	7.94	5.19	9.02	37.56
LIN Linde plc Ordinary Shares	4.56 0.89%	516.71	33.77	28.90	6.56	5.42	7.03	18.92
AIQUY Air Liquide SA ADR	-0.61 1.59%	37.81	30.69	24.81	4.70	4.10	4.36	15.61
AIQUF L'Air Liquide S.A	0.0013 0.0007%	190.41	30.66	24.51	4.69	4.05	4.36	15.61
SHW Sherwin-Williams Co	-3.89 1.21%	316.90	33.33	27.40	3.38	20.60	3.88	21.36

Reports Covered

View All

Profile

Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.

Chr. Hansen Holding A/S

Boege AllE 10-12, Horsholm, Denmark, 2970

45 45 74 74 74
https://www.chr-hansen.com

Key Executives

Name	Title	Year Born
Mr. Mauricio Graber	CEO, Pres & Member of Exec. Board	1963
Ms. Lise Skaarup Mortensen	Exec. VP, CFO & Member of Exec. Board	1968
Dr. Thomas Schafer Ph.D.	Chief Science Advisor	1963
Mr. Torsten Steenholt	Exec. VP of Global Operations	1969
Mr. Henrik Joerck Nielsen	Exec. VP & Chief Scientific Officer	1978
Anders Mohr Christensen	VP Group Strategy & Investor Relations	NA
Ms. Winnie Hoejvang Bugel	Exec. VP of Compliance & Corp. Affairs	1965
Sanne Seyer-Hansen	Head of Media Relations	NA
Ms. Alice Larsen	Exec. VP of HR	1968
Mr. Laurent Hubert	VP & Head of Food, Beverage and Diagnostics	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.